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Twenty-two–year durability of Ionescu-Shiley pericardial aortic
bioprosthesis implanted in a 49-year-old woman: A valuable insight
into the performance of current pericardial bioprostheses
Charles A. Yankah, MD, PhD, Yuguo Weng, MD, Rudolf Meyer, MD, PhD, Henryk Siniawski, MD, PhD, and
Roland Hetzer, MD, PhD, Berlin, Germany
After initial excellent hemodynamic results, the Ionescu-Shiley pericardial bioprosthesis (Shiley, Inc, Irvine,Calif ) demonstrated an unacceptably high rate ofearly structural deterioration. The valve was subse-
quently prohibited for clinical use in 1987. We report the case of
a patient with, to our knowledge, the longest durability of an
Ionescu-Shiley pericardial bioprosthesis (ISPB), which is of his-
torical value. This case provides some valuable insights into the
performance of current pericardial bioprostheses.
Clinical Summary
In 1983 a 49-year-old woman underwent aortic valve replacement
with a 25-mm ISPB and simultaneous replacement of the ascend-
ing aorta for type A dissection with a pre-existing aneurysm. In
2000 she underwent replacement of the aortic arch and descending
aorta in combination with a prosthetic arterial bypass graft to the
left subclavian artery. On the fifth postoperative day, reconstruc-
tion of the trachea was performed because of a tracheal injury. In
2003 the aneurysmal thoracoabdominal aorta was replaced with an
aortic prosthesis at the level of the diaphragm, with an uneventful
postoperative course.
Echocardiographic dimensions in 2000 were as follows: left
ventricular (LV) end-diastolic diameter (LVEDD) 41 mm; LV
end-systolic diameter (LVESD) 30 mm; LV posterior wall thick-
ness in diastole/systole (D/S) 10/17 mm; interventricular septum in
D/S 10/11 mm; transvalvular mean gradient 6 mm Hg; LV ejection
fraction 60%; no aortic regurgitation.
Measurements in 2003 were as follows: LVEDD 52 mm; LVESD
34 mm; LV posterior wall thickness in D/S 11/17 mm; interventric-
ular septum in D/S 13/16 mm; transvalvular mean gradient 10 mm
Hg; LV ejection fraction 60%; no aortic regurgitation.
In December 2004 the patient presented with fever, and echo-
cardiographic examination revealed prosthetic valve endocarditis
with grade 2 aortic regurgitation. Abiotrophia adiacens, previously
referred to as nutritionally variant streptococci, Streptococcus ad-
jacens, and Streptococcus defectivus, was identified in the blood
cultures and was sensitive to ampicillin and gentamicin. She was
discharged home after 14 days of hospitalization. On April 12,
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Figure 1. Explanted valve, ventricular view.
Figure 2. Explanted valve, aortic view. Retracted cusp with 2 re-
maining mobile cusps showing dystrophic changes with minor cal-
cifications and irregularities at the coaptation surfaces. Multifocal
scar tissue was found on the cusps without signs of infection.
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2005, she had increasing shortness of breath with intermittent chest
pain, which led to rehospitalization for clinical assessment and
treatment for heart failure. Echocardiographic study showed LVEDD
62 mm, LVEF 45%, and grade 3 aortic regurgitation of the ISPB.
Blood chemistry studies showed no abnormalities. After successful
treatment for heart failure and exclusion of coronary artery disease
by coronary angiography, she underwent replacement of the ISPB
with a 23-mm Hancock porcine bioprosthesis (Medtronic, Inc,
Minneapolis, Minn) on April 25, 2005. The explanted ISPB
showed dystrophic changes in all 3 cusps (Figures 1 and 2). The
postoperative course was uneventful. The LV function had recov-
ered after 3 months (ejection fraction 55%, LVEDD 55 mm).
Clinically, she was in good cardiovascular condition (New York
Heart Association functional class II) both at an outpatient visit in
August 2005 and at a telephone interview on January 17, 2006.
Comments
This single case report demonstrates that there is potential in the
overall performance of the new-generation pericardial bioprosthe-
ses, particularly in relation to structural valve deterioration in
selected patients younger than 70 years of age.
We have learned from this single case that pericardial biopros-
thesis in general can be implanted in a 50-year-old patient with
comorbidities. Infective endocarditis of a pericardial prosthetic
valve is a relatively uncommon complication occurring in 0.2%/
patient-year,1 and its late occurrence is less common. Acceleration
of structural deterioration of the pericardial tissue valve resulted in
valve incompetence and compromised the LV function in this
patient.
The low-profile ISPB demonstrated excellent hemodynamic
performance and had preserved the LV function for more than 22
years. Finally, this case also supports the fact that new-generation
pericardial bioprostheses may show the same long-term durability
in patients younger than 70 years of age with comorbidities, as was
demonstrated in our 17-year clinical study,1 as well as in other
publications.2
We thank Professor Hans Borst for his contribution and Anne
Gale for editorial assistance.
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The disk of bileaflet mechanical mitral valve prosthesis jammed by
ruptured papillary muscle
Marcin Fijalkowski, MD, Andrzej Koprowski, MD, PhD, Rafal Pawlaczyk, MD, PhD, Piotr Siondalski, MD, PhD,
Rafal Galaska, MD, Jan Rogowski, MD, PhD, and Andrzej Rynkiewicz, MD, PhD, Gdansk, Poland
The incidence and natural history of papillary musclerupture occurring after chord-sparing mitral valve re-placement for ischemic mitral insufficiency are un-known. A case in which this complication occurred
after chord-sparing mitral valve replacement is described.
Clinical Summary
A 59-year-old man was admitted to our institution with acute heart
failure symptoms and chest discomfort lasting for 3 days. The
electrocardiogram showed sinus tachycardia (115 beats/min) and
pathologic Q waves in the II, III, and aVF leads. The serum
concentrations of creatine kinase MB and troponin I were signif-
icantly elevated. A chest radiograph revealed pulmonary edema.
Two-dimensional transthoracic echocardiography showed akinesia
of inferior and posterior walls and severe mitral regurgitation
caused by posterior leaflet restriction (vena contracta 7 mm).
Coronary angiography showed occluded right and circumflex cor-
onary arteries and a critically narrowed left anterior descending
coronary artery.
On the basis of these findings, mitral valve surgery and coro-
nary artery bypass grafting were recommended. Treatment with
intra-aortic balloon pump support was started, without significant
improvement. Emergency cardiosurgery was performed because of
the patient’s unstable condition. The mitral valve was replaced
with a 29-mm Medtronic Advantage prosthesis (Medtronic, Inc,
Minneapolis, Minn) placed in antianatomic position with preser-
vation of the posterior leaflet (ring annuloplasty was not success-
ful). Coronary artery revascularization was done in the same
operation.
The early postoperative course was uneventful. At the end of
the second week of hospitalization, hypotension and pulmonary
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